Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma.
Faye MD, Easaw J, De Robles P, Agnihotram R, Torres-Vasquez A, Lamonde F, Petrecca K, Owen S, Panet-Raymond V, Shenouda G, Souhami L, Azam M, Hossain B, Alkass J, Sabri S, Abdulkarim B.
Faye MD, et al.
Neurooncol Adv. 2023 Sep 12;5(1):vdad106. doi: 10.1093/noajnl/vdad106. eCollection 2023 Jan-Dec.
Neurooncol Adv. 2023.
PMID: 37771465
Free PMC article.